RxDoctor Payments Data

Ashley Branham, APRN

Adult Health · Pikeville, KYNPI 1811390776

Payments from drug & device makers

$572in general payments, 2019–2025

Across 29 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$280
  • AbbVie$79
  • Dexcom, Inc.$70
  • Novo Nordisk$51
  • Abbott$17
  • Lilly USA, LLC$17
  • plus $57 from 4 others

What the payments were for

  • Food & beverage$572100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$572 in reported general payments places this provider in the 50th percentile of 170 adult health providers in Kentucky.

See all adult health providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,657
Medicare patients
72
Services billed
271

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate63$54,889
JardianceEmpagliflozin62$49,017
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$48,269
OzempicSemaglutide29$32,277
MounjaroTirzepatide26$28,789
FarxigaDapagliflozin Propanediol21$22,674
Spiriva RespimatTiotropium Bromide30$21,993
Breo ElliptaFluticasone/Vilanterol36$16,609
EliquisApixaban20$15,015
LinzessLinaclotide16$13,428
UbrelvyUbrogepant12$12,183
Ventolin HfaAlbuterol Sulfate162$11,134
Stiolto RespimatTiotropium Br/Olodaterol Hcl18$10,573
Incruse ElliptaUmeclidinium Bromide23$10,317
Albuterol Sulfate HfaAlbuterol Sulfate219$8,160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$280$81,583110 claims
Novo NordiskOzempic$51$32,27729 claims
Lilly USA, LLCMounjaro$17$28,78926 claims
AbbVieLinzess, Ubrelvy$79$25,61228 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 170 adult health providers in Kentucky.

Other adult health in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →